Gerhard Müller-Newen
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 28, 2025
Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. Cancers 2020, 12, 3412.Cristina Maranto, Vindhya Udhane, Jing Jia
|Feb 15, 2022
Phenotypic variability, not noise, accounts for most of the cell-to-cell heterogeneity in IFN-γ and oncostatin M signaling responses.Piotr Topolewski, Karolina E Zakrzewska, Jarosław Walczak
|Nov 21, 2020
Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.Cristina Maranto, Vindhya Udhane, Jing Jia
|Nov 23, 2019
Nucleocytoplasmic Shuttling of STATs. A Target for Intervention?Sabrina Ernst, Gerhard Müller-Newen
|Mar 08, 2019
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling.Maja Kim Kuepper, Marlena Bütow, Oliver Herrmann
Pageof 1
Frequent Collaborators
2 joint publications
Michael Pereckas
2 joint publications
Vincent C O Njar
2 joint publications
Liang Wang
1 joint publications
Nicolas Chatain
1 joint publications
Ivan G Costa
1 joint publications
Steffen Koschmieder
1 joint publications
Karolina E Zakrzewska
1 joint publications
Jarosław Walczak
1 joint publications
Karol Nienałtowski
1 joint publications
Michał Komorowski
